Elena Kralidis
6 Papers
Elena Kralidis is an academic researcher. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Viviana Galimberti,Bernard F. Cole,Giuseppe Viale,Giuseppe Viale,Paolo Veronesi,Paolo Veronesi,Elisa Vicini,Mattia Intra,Giovanni Mazzarol,Samuele Massarut,Janez Zgajnar,Mario Taffurelli,David Littlejohn,Michael Knauer,Carlo Tondini,Angelo Di Leo,Marco Colleoni,Meredith M. Regan,Alan S. Coates,Richard D. Gelber,Aron Goldhirsch,Frances M. Boyle,Guy Jerusalem,Rolf A. Stahel,Stefan Aebi,Michael D. Green,Per Karlsson,Ingrid Kössler,István Láng,Anita Hiltbrunner,Jürg Bernhard,Stamatina Fournarakou,Roswitha Kammler,Rudolf Maibach,Manuela Rabaglio,Karin Ribi,Heidi Roschitzki,Susanne Roux,Barbara Ruepp,Caitlin Mahoney,Karen N. Price,Lynette Blacher,Tara Scolese,Karolyn Scott,Sandra Lippert,Theresa Zielinski,Mauro G. Mastropasqua,Stefania Andrighetto,Patrizia Dell'Orto,Giuseppe Renne,Giancarlo Pruneri,Silvia Dellapasqua,Monica Iorfida,Giuseppe Cancello,Emilia Montagna,Anna Cardillo,Giulia Peruzzotti,R. Ghisini,Alberto Luini,Umberto Veronesi,Oreste Gentilini,Stefano Zurrida,Giuseppe Curigliano,Franco Nolè,Roberto Orecchia,Marisa Cristina Leonardi,Paola Baratella,Camelia Chifu,Manuela Sargenti,Diana Crivellari,Sandro Morassut,Mario Mileto,Erica Piccoli,Andreas Veronesi,Marisa Donatella Magri,Angelo Buonadonna,Ezio Candiani,Antonino Carbone,Tiziana Perin,Rachele Volpe,Mario Roncadin,Mauro Arcicasa,Francesco Coran,Manuela Lagrassa,Angelo Recalcati,Maria Emanuela Limonta,Paolo Tricomi,Privato Fenaroli,Elisabetta Candiago,Laura Cattaneo,Alberto Gianatti,Donatella Santini,Sylvie Maweja,Philippe Delvenne,Andrée Rorive,Joëlle Collignon,Jean-Remi Garbay,Marie-Christine Mathieu,Hanne Galatius,Jack Hoffmann,Peer Schousen,Charlotte Lanng,John Hoerby,Birgitte Bruun Rasmussen,Helle Holtveg,Maj-Lis Moeller Talman,Julio Abugattas,Jose Manuel Cotrina,Richard Dyer,Jurij Lindtner,Elga Majdic,Snjezana Frkovic-Grazio,Christian Oehlschlegel,Gerhard Ries,Michael Töpfer,Ute Lorenz,Otto Schiltknecht,Bruno Späti,Andreas Ehrsam,Monika Bamert,Martina Egli-Tupaj,Christoph Rageth,Elisabeth Saurenmann,Christoph Tausch,Rosmarie Caduff,Holger Moch,Zsuzsanna Varga,Dimitri Sarlos,Elena Kralidis,Rainer Grobholz,Olivia Pagani,Lucia Bronz,Michele Ghielmini,Luca Mazzucchelli,Tiziana Rusca,Thomas Gyr,Linda Leidi,Giorgio Caccia,Daniel Wyss,Martin F. Fey,Michael Müller,Andreas Günthert,Gilles Berclaz,Achim Fleischmann,Jean Francois Delaloye,Assia Treboux,Hans-Anton Lehr,Maryse Fiche,L Perey,Lucien Zaman,Wendy Jeanneret Sozzi,John F. Forbes,D. F. Lindsay,D.F. Preece,Jane Hill,P. Jeal,P. Smart,John J. Collins,Gregory Bruce Mann,Robert Millar,Craig Murphy,Malcolm Buchanan,Anand Murugasu,James French,Elisabeth Elder,Lynette Mann,David Moon,A. Michael Bilous,Nirmala Pathmanathan,Virginia Howard,Petere G. Gill,James Kollias,Melissa Bochner,Linda Madigan,Elisabeth Rippy,Robert Whitfield,Fereshte Farshidi,Katrina Moore,Mark Sywak,L. Tan,William Ross,Karen Briscoe,Allison Jones,Aashit Shah,Elgene Lim,Robert Macindoe,Andrew J. Spillane,S. Fiona Bonar,Hugh Carmalt,Richard West,Cindy Mak,Paul McKenzie,Richard Harman,Susanne Gerred,Eva Juhasz,Stephen Allpress,Julie Craik,Ian G. Campbell,Paul Chin,Lori Hayes,Frederick Mayall,M. Thorburn +201 more
TL;DR: The findings of the IBCSG 23-01 trial corroborate those obtained at 5 years and are consistent with those of the 10-year follow-up analysis of the Z0011 trial, and support the current practice of not doing an axillary dissection when the tumour burden in the sentinel nodes is minimal or moderate.
456
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial
Thomas Ruhstaller,Anita Giobbie-Hurder,Marco Colleoni,Maj-Britt Jensen,Bent Ejlertsen,Evandro de Azambuja,Patrick Neven,István Láng,Erik Jakobsen,Laurence Gladieff,Hervé Bonnefoi,Vernon Harvey,Simon Spazzapan,Carlo Tondini,Lucia Del Mastro,Corinne Veyret,Edda Simoncini,Lorenzo Gianni,Christoph Rochlitz,Elena Kralidis,Khalil Zaman,Jacek Jassem,Martine Piccart-Gebhart,Angelo Di Leo,Richard D. Gelber,Alan S. Coates,Aron Goldhirsch,Beat Thürlimann,Meredith M. Regan +28 more
TL;DR: This study illustrates the value of extended follow-up in trials of luminal breast cancer and finds Reporting of specific long-term adverse events seemed more effective with national registry than with case-record reporting of clinical follow- up.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
N. Colombo,Angiolo Gadducci,J. Sehouli,Erica Rulli,N. B. Ottevanger,Ignace Vergote,Maurizio D'Incalci,Radoslav Chekerov,Gitte-Bettina Nyvang,Salome Riniker,Roldano Fossati,M. Barretina-Ginesta,Mustafa Deryal,Mansoor Raza Mirza,Mercedes Iglesias,Gusmão Funari,Margarita Romeo,Andrea Decensi,Ugo De Giorgi,Paolo Zola,Pierluigi Benedetti Panici,Massimo Aglietta,Claudio Zamagni,Anne Westermann,Viola Heinzelmann-Schwarz,I Tsibulak,Pauline Wimberger,Andres Poveda,Nicoletta Colombo,Eliana Rulli,Elena Biagioli,Lucia Carlucci,Davide Poli,Giulia Tasca,Maria Ornella Nicoletto,Germana Tognon,Dionyssios Katsaros,Innocenza Palaia,Valentina Arcangeli,Alessandra Bologna,Alessandro Bertolini,Cinzia Caroti,Milena Bruzzone,Nicoletta Donadello,Gianna Di Costanzo,Alberto Zaniboni,Daniela Surico,Roberta Buosi,Enrico Cortesi,Elena Zafarana,Vittorio Fusco,L. Zavallone,Teresa Gamucci,Filomena Narducci,Valentina Musacchi,Luciana Babilonti,Annamaria Ferrero,Luigi Cavanna,Roberto Sabbatini,Stefano Tamberi,G. Artioli,Antonio Ardizzoia,Alessia Caldara,Zuzana Sirotovà,C. Casartelli,Michele Aieta,Saverio Cinieri,Elvira De Marino,Stefania Gori,Francesco Ferraù,Livio Blasi,Massimiliano Alù,Sabino De Placido,Carlo Milandri,Maria-Pilar Barretina-Ginesta,Isabel Bover,Beatriz Pardo,Maria J. Rubio-Pérez,Ana Santaballa,Raul Marquez,Jesus Alarcón,C. Caballero-Díaz,Eugenia Ortega,Maria Angeles Arcusa Lanza,Elena Garcia Martinez,Regina Gironés,Y. García,Cesar Mendiola,Ana Beatriz Sanchez,Jalid Sehouli,Georg Heinrich,Ingo B. Runnebaum,Fabian Trillsch,G. Oskay-Özcelik,Maike de Wit,Eva-Maria Grischke,Dirk Bauerschlag,Florian Heitz,Alexander Mustea,Tanja Fehm,Andrea Heider,Max Dieterich,Marco Battista,Achim Woeckel,Ivo Meinhold-Heerlein,Ana Montes,R. A. Herbertson,Emma Hudson,R. Bowen,Lionel D'Hondt,Peter Vuylsteke,Christof Vulsteke,Petronella B. Ottevanger,Anneke M. Westermann,Cristiana Sessa,Roger von Moos,Elena Kralidis,Stefan Aebi,C. Uhlmann Nussbaum,M. Fehr,Andreas Müller,Christian Taverna,Johanna Mäenpää,Gunnar B. Kristensen,Anne Gry Bentzen,Bent Fiane,Ulla Puistola,Maarit Anttila,Christian Barth,Regina Berger,Edgar Petru,Christian Schauer,Alexander Reinthaller +132 more
TL;DR: In this paper , the authors investigated the hypothesis that the treatment with trabectedin/PLD (TP) to extend the platinum-free interval (TFIp) can improve overall survival (OS) in patients with recurrent ovarian cancer.
SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients
Marcus Vetter,Karin M. Rothgiesser,Qiyu Li,Hanne Hawle,W. Schönfeld,Karin Ribi,Salome Riniker,Roger von Moos,Andreas Trojan,Elena Kralidis,Mathias K. Fehr,Andreas Müller,B. Thuerlimann +12 more
TL;DR: Despite this trial is negative, the 24% DC24 rate in a second-line setting, and the prolonged partial response experienced by a patient, indicate activity of CR1447.
Final overall survival analysis of the phase II SAKK 21/12 trial of transdermal CR1447 in patients with metastatic breast cancer
Marcus Vetter,Lisa Holer,K. Rothgiesser,W. Schönfeld,Salome Riniker,R. von Moos,Andreas Trojan,Elena Kralidis,Manuela Rabaglio,Mathias K. Fehr,Markus Borner,Lorenzo Rossi,C. Kurzeder,Beat Thürlimann +13 more